top of page

LATEST NEWS

October 2023

  • All the links have been checked and are working properly.

  • Plitidepsin: The compound has been removed as it currently has active Phase 3 clinical trial. Plitidepsin is moved to Phase 2 for an active clinical trial for Coronavirus.

August 2023

  • All the links have been checked and were working properly.

June 2023

  • The new UPDATE report was discussed and will be posted for June 2023.

  • All the links have been checked and were working properly.

  • Marizomib (Salinosporamide A; NPI-0052) is now in the Bristol Myers Squibb pipeline.

April 2023

  • The new UPDATE report was discussed and will be posted for April 2023.

  • The following clinical trial numbers have changed:

  • Ladiratuzumab vedotin (SGN-LIV1A) a. “[5+]” to “[4+]” under US – Active Clinical Trials

February 2023

  • All the links have been checked and were working properly. Recent changes in the number of active clinical trials in Phase 3 are shown below.

  • Plitidepsin has a new US Active Phase 3 trial that is updated to the Phase 3 webpage.

  • Upiftamab rilsodotin (XMT-1536) has a new US Active and European Active Phase 3 trial that is updated to the Phase 3 webpage.

December 2022

  • All the links have been checked and were working properly. The number of clinical trials in Phase 3 is currently reflected on the website.  

September 2022

  • During September copyright notices were posted on the top and bottom of this page.

  • Plinabulin has 5 US Active Trials.

  • XMT-1536 (upifitamab rilsodotin) has a new US Active Phase 3 trial has been added to the Phase 3 webpage.   

Approved Marine Drugs
© 2021-2024 Marine Pharmacology
© 2021-2024 Marine Pharmacology
bottom of page